LONDON and GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® ...
Starting July 1, 2025, additional opioid overdose response tools will be available to continue addressing evolving patient and customer needs to combat public health crisis GAITHERSBURG, Md., July 02, ...
The three-year shelf-life extension improves naloxone access for communities and first responders who continue to fight the growing opioid epidemic ALLEGAN, Mich., April 2, 2025 /PRNewswire/ -- ...
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone ...
Emergent BioSolutions Inc. has expanded its NARCANDirect® online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg, enhancing access to opioid overdose response products for ...
If approved by the FDA, NARCAN Nasal Spray will be the first 4 mg naloxone nasal spray switched from prescription status to over-the-counter use GAITHERSBURG, Md., Feb. 15, 2023 (GLOBE NEWSWIRE) -- ...
In support of the launch, the healthcare company, in partnership with non-profit End Overdose, is educating Americans on how to administer this lifesaving medication that can reverse the effects of an ...
In the latest maneuver in the battle against opioid deaths in California, Gov. Gavin Newsom announced Monday that all Californians can now buy naloxone anti-overdose nasal spray directly the state for ...
The US Food and Drug Administration (FDA) has granted final approval for the first generic naloxone hydrochloride nasal spray (Narcan, Teva Pharmaceuticals) that can stop or reverse the effects of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results